Your browser doesn't support javascript.
loading
Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.
Song, Kai; Minami, Jenna K; Huang, Arthur; Dehkordi, Siavash R; Lomeli, Shirley H; Luebeck, Jens; Goodman, Mark H; Moriceau, Gatien; Krijgsman, Oscar; Dharanipragada, Prashanthi; Ridgley, Trevor; Crosson, William P; Salazar, Jesus; Pazol, Eli; Karin, Gabriel; Jayaraman, Rachana; Balanis, Nikolas G; Alhani, Salwan; Sheu, Kyle; Ten Hoeve, Johanna; Palermo, Amelia; Motika, Stephen E; Senaratne, T Niroshi; Paraiso, Kim H; Hergenrother, Paul J; Rao, P Nagesh; Multani, Asha S; Peeper, Daniel S; Bafna, Vineet; Lo, Roger S; Graeber, Thomas G.
Affiliation
  • Song K; Department of Bioengineering, University of California, Los Angeles, California.
  • Minami JK; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Huang A; Department of Integrative Biology and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Dehkordi SR; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Lomeli SH; Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California.
  • Luebeck J; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Goodman MH; Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California.
  • Moriceau G; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Krijgsman O; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Dharanipragada P; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Ridgley T; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Crosson WP; Bioinformatics Interdepartmental Program, University of California, Los Angeles, California.
  • Salazar J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Pazol E; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Karin G; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Jayaraman R; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Balanis NG; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Alhani S; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Sheu K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Ten Hoeve J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Palermo A; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Motika SE; University of California, Los Angeles, Metabolomics Center, Los Angeles, California.
  • Senaratne TN; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Paraiso KH; University of California, Los Angeles, Metabolomics Center, Los Angeles, California.
  • Hergenrother PJ; Department of Chemistry, Institute for Genomic Biology, Cancer Center at Illinois, University of Illinois, Urbana-Champaign, Illinois.
  • Rao PN; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Multani AS; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Peeper DS; Department of Chemistry, Institute for Genomic Biology, Cancer Center at Illinois, University of Illinois, Urbana-Champaign, Illinois.
  • Bafna V; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Lo RS; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Graeber TG; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Cancer Discov ; 12(4): 1046-1069, 2022 04 01.
Article in En | MEDLINE | ID: mdl-34930786
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Melanoma Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Melanoma Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Document type: Article Country of publication: United States